Latest News and Press Releases
Want to stay updated on the latest news?
-
IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for...
-
IRVINE, Calif., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, a family owned genetic testing Company, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance...
-
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
-
BOCA RATON, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
-
Poster presentations to highlight new quantitative and serologic diagnostic methods for Celiac Disease detection and determination of intestinal mucosal health New tools may serve as companion...
-
LOS ANGELES, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Celiac disease, an autoimmune disorder caused by gluten intolerance, affects about 1 in 100 Americans and happens when Gliadin, a protein in wheat,...
-
LOS ANGELES, Aug. 11, 2014 (GLOBE NEWSWIRE) -- With America's increasing awareness of serious weight-related diseases and conditions, including gluten allergies, discovering the key to better health...